| Title |
Statins for the primary prevention of cardiovascular disease
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2013
|
| DOI | 10.1002/14651858.cd004816.pub5 |
| Pubmed ID | |
| Authors |
Fiona Taylor, Mark D Huffman, Ana Filipa Macedo, Theresa HM Moore, Margaret Burke, George Davey Smith, Kirsten Ward, Shah Ebrahim, Hawkins C Gay |
| Abstract |
Reducing high blood cholesterol, a risk factor for cardiovascular disease (CVD) events in people with and without a past history of CVD is an important goal of pharmacotherapy. Statins are the first-choice agents. Previous reviews of the effects of statins have highlighted their benefits in people with CVD. The case for primary prevention was uncertain when the last version of this review was published (2011) and in light of new data an update of this review is required. |
X Demographics
The data shown below were collected from the profiles of 211 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 34 | 16% |
| United States | 31 | 15% |
| Spain | 11 | 5% |
| Australia | 8 | 4% |
| France | 4 | 2% |
| Canada | 4 | 2% |
| Netherlands | 4 | 2% |
| Ireland | 3 | 1% |
| Japan | 3 | 1% |
| Other | 22 | 10% |
| Unknown | 87 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 144 | 68% |
| Practitioners (doctors, other healthcare professionals) | 33 | 16% |
| Scientists | 23 | 11% |
| Science communicators (journalists, bloggers, editors) | 9 | 4% |
| Unknown | 2 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,034 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | <1% |
| Netherlands | 3 | <1% |
| United Kingdom | 3 | <1% |
| Chile | 2 | <1% |
| France | 2 | <1% |
| Canada | 2 | <1% |
| Austria | 1 | <1% |
| Brazil | 1 | <1% |
| Italy | 1 | <1% |
| Other | 3 | <1% |
| Unknown | 1012 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 155 | 15% |
| Student > Master | 138 | 13% |
| Researcher | 119 | 12% |
| Student > Ph. D. Student | 103 | 10% |
| Other | 77 | 7% |
| Other | 213 | 21% |
| Unknown | 229 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 456 | 44% |
| Biochemistry, Genetics and Molecular Biology | 56 | 5% |
| Nursing and Health Professions | 48 | 5% |
| Agricultural and Biological Sciences | 48 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 45 | 4% |
| Other | 126 | 12% |
| Unknown | 255 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 498. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 November 2023.
All research outputs
#50,118
of 24,833,726 outputs
Outputs from Cochrane database of systematic reviews
#93
of 12,985 outputs
Outputs of similar age
#273
of 293,791 outputs
Outputs of similar age from Cochrane database of systematic reviews
#2
of 172 outputs
Altmetric has tracked 24,833,726 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,985 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 293,791 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 172 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.